These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

494 related items for PubMed ID: 9613715

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. What process causes nigral cell death in Parkinson's disease?
    Jenner P.
    Neurol Clin; 1992 May; 10(2):387-403. PubMed ID: 1584181
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Iron metabolism and Parkinson's disease.
    Hirsch EC, Faucheux BA.
    Mov Disord; 1998 May; 13 Suppl 1():39-45. PubMed ID: 9613717
    [Abstract] [Full Text] [Related]

  • 5. Nitric oxide and reactive oxygen species in Parkinson's disease.
    Tieu K, Ischiropoulos H, Przedborski S.
    IUBMB Life; 2003 Jun; 55(6):329-35. PubMed ID: 12938735
    [Abstract] [Full Text] [Related]

  • 6. Alpha-synuclein redistributes to neuromelanin lipid in the substantia nigra early in Parkinson's disease.
    Halliday GM, Ophof A, Broe M, Jensen PH, Kettle E, Fedorow H, Cartwright MI, Griffiths FM, Shepherd CE, Double KL.
    Brain; 2005 Nov; 128(Pt 11):2654-64. PubMed ID: 16000336
    [Abstract] [Full Text] [Related]

  • 7. Oxidative stress in Parkinson's disease and other neurodegenerative disorders.
    Jenner P.
    Pathol Biol (Paris); 1996 Jan; 44(1):57-64. PubMed ID: 8734302
    [Abstract] [Full Text] [Related]

  • 8. Early signs of neuronal apoptosis in the substantia nigra pars compacta of the progressive neurodegenerative mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/probenecid model of Parkinson's disease.
    Novikova L, Garris BL, Garris DR, Lau YS.
    Neuroscience; 2006 Jun 19; 140(1):67-76. PubMed ID: 16533572
    [Abstract] [Full Text] [Related]

  • 9. Altered mitochondrial function, iron metabolism and glutathione levels in Parkinson's disease.
    Jenner P.
    Acta Neurol Scand Suppl; 1993 Jun 19; 146():6-13. PubMed ID: 8333254
    [Abstract] [Full Text] [Related]

  • 10. Heredity in Parkinson's disease: new findings.
    Lev N, Melamed E.
    Isr Med Assoc J; 2001 Jun 19; 3(6):435-8. PubMed ID: 11433638
    [Abstract] [Full Text] [Related]

  • 11. The oxidant stress hypothesis in Parkinson's disease: evidence supporting it.
    Fahn S, Cohen G.
    Ann Neurol; 1992 Dec 19; 32(6):804-12. PubMed ID: 1471873
    [Abstract] [Full Text] [Related]

  • 12. Oxidative stress as a cause of nigral cell death in Parkinson's disease and incidental Lewy body disease. The Royal Kings and Queens Parkinson's Disease Research Group.
    Jenner P, Dexter DT, Sian J, Schapira AH, Marsden CD.
    Ann Neurol; 1992 Dec 19; 32 Suppl():S82-7. PubMed ID: 1510385
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Free radical and nitric oxide toxicity in Parkinson's disease.
    Przedborski S, Jackson-Lewis V, Vila M, Wu DC, Teismann P, Tieu K, Choi DK, Cohen O.
    Adv Neurol; 2003 Dec 19; 91():83-94. PubMed ID: 12442666
    [No Abstract] [Full Text] [Related]

  • 15. The therapeutic potential of neurotrophic factors in the treatment of Parkinson's disease.
    Lindsay RM, Altar CA, Cedarbaum JM, Hyman C, Wiegand SJ.
    Exp Neurol; 1993 Nov 19; 124(1):103-18. PubMed ID: 8282068
    [Abstract] [Full Text] [Related]

  • 16. Effect of centrophenoxine against rotenone-induced oxidative stress in an animal model of Parkinson's disease.
    Verma R, Nehru B.
    Neurochem Int; 2009 Nov 19; 55(6):369-75. PubMed ID: 19375462
    [Abstract] [Full Text] [Related]

  • 17. Pathogenesis and animal studies of Parkinson's disease.
    Oertel WH, Kupsch A.
    Curr Opin Neurol Neurosurg; 1993 Jun 19; 6(3):323-32. PubMed ID: 8507901
    [Abstract] [Full Text] [Related]

  • 18. Pathogenesis of Parkinson's disease.
    Schapira AH.
    Baillieres Clin Neurol; 1997 Apr 19; 6(1):15-36. PubMed ID: 9426866
    [Abstract] [Full Text] [Related]

  • 19. Glial pathology but absence of apoptotic nigral neurons in long-standing Parkinson's disease.
    Banati RB, Daniel SE, Blunt SB.
    Mov Disord; 1998 Mar 19; 13(2):221-7. PubMed ID: 9539333
    [Abstract] [Full Text] [Related]

  • 20. Alterations in glutathione levels in Parkinson's disease and other neurodegenerative disorders affecting basal ganglia.
    Sian J, Dexter DT, Lees AJ, Daniel S, Agid Y, Javoy-Agid F, Jenner P, Marsden CD.
    Ann Neurol; 1994 Sep 19; 36(3):348-55. PubMed ID: 8080242
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.